We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Loses Generic Actonel Case, But Wins Protonix Lawsuit
Teva Loses Generic Actonel Case, But Wins Protonix Lawsuit
May 26, 2009
Teva Pharmaceuticals USA has lost its latest bid to invalidate a patent covering Procter & Gamble’s (P&G) osteoporosis drug Actonel, but it still can sell its generic version of Protonix, according to separate federal court rulings.